506-17-2
506-17-2
Chemical Structure
cis-Vaccenic acid
- CAS No.: 506-17-2
- Formula:C18H34O2
- Molecular Weight:282.46
IUPAC Name: (Z)-octadec-11-enoic acid
InChIKey: UWHZIFQPPBDJPM-FPLPWBNLSA-N
SMILES: CCCCCC/C=C\CCCCCCCCCC(O)=O
Biological Activity: cis-Vaccenic acid, the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate[1], acts a potential fetal hemoglobin inducer[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
cis-Vaccenic acid | 99.91% | cis-Vaccenic acid, the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate, acts a potential fetal hemoglobin inducer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
cis-Vaccenic acid-d13 | cis-Vaccenic acid-d13 is the deuterium labeled cis-Vaccenic acid. cis-Vaccenic acid, the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate, acts a potential fetal hemoglobin inducer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. H Hirotani, et al. Inactivation of T5 phage by cis-vaccenic acid, an antivirus substance from Rhodopseudomonas capsulata, and by unsaturated fatty acids and related alcohols. FEMS Microbiol Lett. 1991 Jan 1;61(1):13-7. [Content Brief]
- [2]. Idowu A Aimola, et al. Cis-vaccenic acid induces differentiation and up-regulates gamma globin synthesis in K562, JK1 and transgenic mice erythroid progenitor stem cells. Eur J Pharmacol. 2016 Apr 5;776:9-18. [Content Brief]
